Therapure Biopharma may consider joint ventures or co-development structures with mature companies developing biologics. As the ability to manufacture biological products is key to the approval and ultimate success of the product, Therapure Biopharma has the potential to bring considerably more value as a partner than either a pure financial investor or a contract service provider ever could.

Therapure Biopharma is not a venture capital company, but where we have a relationship with a client that fits our development and manufacturing expertise, we will consider targeted investments in line with our strategic interests.